The Exchange has sought clarification from Amrutanjan Health Care Limited with respect to recent news item captioned Amrutanjan held Mylapore Kapaleeswarar Temple land till 2018; Rs 9.74 crore dues: HR&CE tells HC. The response from the Company is attached.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Amrutanjan Health Care responded to an NSE query about a news article claiming the company held Mylapore Kapaleeswarar Temple land till 2018 with Rs 9.74 crore dues to HR&CE. The company clarified this refers to an old 2005 writ petition (Writ Petition No. 35484 of 2005) that has now been decided by the Madras High Court, with the order copy received only on March 17, 2026. The company stated no undisclosed negotiations or information triggered any unusual trading. Importantly, Amrutanjan said the article will not impact its business or operations, the matter was already disclosed as a contingent liability in its Annual Reports, and the news item contains factually incorrect information.
This is largely a housekeeping clarification on a legacy legal matter. Shareholders should note the company is contesting the accuracy of the news and claims no material business impact. The Madras HC order details are now expected to be formally disclosed under SEBI LODR Regulation 30, so investors should watch for the next filing with the actual order copy.